Cargando…
In silico comparative characterization of pharmacogenomic missense variants
BACKGROUND: Missense pharmacogenomic (PGx) variants refer to amino acid substitutions that potentially affect the pharmacokinetic (PK) or pharmacodynamic (PD) response to drug therapies. The PGx variants, as compared to disease-associated variants, have not been investigated as deeply. The ability t...
Autores principales: | Li, Biao, Seligman, Chet, Thusberg, Janita, Miller, Jackson L, Auer, Jim, Whirl-Carrillo, Michelle, Capriotti, Emidio, Klein, Teri E, Mooney, Sean D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092878/ https://www.ncbi.nlm.nih.gov/pubmed/25057096 http://dx.doi.org/10.1186/1471-2164-15-S4-S4 |
Ejemplares similares
-
PharmGKB: A worldwide resource for pharmacogenomic information
por: Barbarino, Julia M., et al.
Publicado: (2018) -
An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics
por: Li, Binglan, et al.
Publicado: (2022) -
An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
por: Whirl‐Carrillo, Michelle, et al.
Publicado: (2021) -
Pharmacogenomics Clinical Annotation Tool (PharmCAT)
por: Sangkuhl, Katrin, et al.
Publicado: (2019) -
The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge
por: Hernandez-Boussard, Tina, et al.
Publicado: (2008)